BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma J, Shepardson K, Johns LL, Wellham J, Avera J, Schwarz B, Rynda-Apple A, Douglas T. A Self-Adjuvanted, Modular, Antigenic VLP for Rapid Response to Influenza Virus Variability. ACS Appl Mater Interfaces 2020;12:18211-24. [PMID: 32233444 DOI: 10.1021/acsami.9b21776] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim D, Wu Y, Kim YB, Oh YK. Advances in vaccine delivery systems against viral infectious diseases. Drug Deliv Transl Res 2021;11:1401-19. [PMID: 33694083 DOI: 10.1007/s13346-021-00945-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Tiwari AK, Mishra A, Pandey G, Gupta MK, Pandey PC. Nanotechnology: A Potential Weapon to Fight against COVID‐19. Part & Part Syst Charact 2022;39:2100159. [DOI: 10.1002/ppsc.202100159] [Reference Citation Analysis]
3 Rahikainen R, Rijal P, Tan TK, Wu H, Andersson AC, Barrett JR, Bowden TA, Draper SJ, Townsend AR, Howarth M. Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation. Angew Chem 2021;133:325-34. [DOI: 10.1002/ange.202009663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Abolnik C, Smith T, Wandrag DB, Murphy M, Rautenbach M, Olibile O, O'kennedy M. Dose immunogenicity study of a plant-produced influenza virus-like particle vaccine in layer hens. Heliyon 2022;8:e09804. [DOI: 10.1016/j.heliyon.2022.e09804] [Reference Citation Analysis]
5 Aebischer A, Wernike K, König P, Franzke K, Wichgers Schreur PJ, Kortekaas J, Vitikainen M, Wiebe M, Saloheimo M, Tchelet R, Audonnet JC, Beer M. Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model. Vaccines (Basel) 2021;9:651. [PMID: 34203630 DOI: 10.3390/vaccines9060651] [Reference Citation Analysis]
6 Loo YS, Bose RJ, McCarthy JR, Mat Azmi ID, Madheswaran T. Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications. Drug Discov Today 2021;26:902-15. [PMID: 33383213 DOI: 10.1016/j.drudis.2020.12.017] [Reference Citation Analysis]
7 Rahikainen R, Rijal P, Tan TK, Wu HJ, Andersson AC, Barrett JR, Bowden TA, Draper SJ, Townsend AR, Howarth M. Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation. Angew Chem Int Ed Engl 2021;60:321-30. [PMID: 32886840 DOI: 10.1002/anie.202009663] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
8 Shin MD, Shukla S, Chung YH, Beiss V, Chan SK, Ortega-rivera OA, Wirth DM, Chen A, Sack M, Pokorski JK, Steinmetz NF. COVID-19 vaccine development and a potential nanomaterial path forward. Nat Nanotechnol 2020;15:646-55. [DOI: 10.1038/s41565-020-0737-y] [Cited by in Crossref: 197] [Cited by in F6Publishing: 172] [Article Influence: 98.5] [Reference Citation Analysis]
9 Zaheer T, Pal K, Zaheer I. Topical review on nano-vaccinology: Biochemical promises and key challenges. Process Biochem 2021;100:237-44. [PMID: 33013180 DOI: 10.1016/j.procbio.2020.09.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Wang Y, Douglas T. Bioinspired Approaches to Self-Assembly of Virus-like Particles: From Molecules to Materials. Acc Chem Res 2022;55:1349-59. [PMID: 35507643 DOI: 10.1021/acs.accounts.2c00056] [Reference Citation Analysis]
11 Nkanga CI, Steinmetz NF. The pharmacology of plant virus nanoparticles. Virology 2021;556:39-61. [PMID: 33545555 DOI: 10.1016/j.virol.2021.01.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Medhi R, Srinoi P, Ngo N, Tran H, Lee TR. Nanoparticle-Based Strategies to Combat COVID-19. ACS Appl Nano Mater 2020;3:8557-80. [DOI: 10.1021/acsanm.0c01978] [Cited by in Crossref: 89] [Cited by in F6Publishing: 36] [Article Influence: 44.5] [Reference Citation Analysis]
13 Lampinen V, Heinimäki S, Laitinen OH, Pesu M, Hankaniemi MM, Blazevic V, Hytönen VP. Modular vaccine platform based on the norovirus-like particle. J Nanobiotechnology 2021;19:25. [PMID: 33468139 DOI: 10.1186/s12951-021-00772-0] [Reference Citation Analysis]
14 Hofmann T, Krah S, Sellmann C, Zielonka S, Doerner A. Greatest Hits-Innovative Technologies for High Throughput Identification of Bispecific Antibodies. Int J Mol Sci 2020;21:E6551. [PMID: 32911608 DOI: 10.3390/ijms21186551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Butkovich N, Li E, Ramirez A, Burkhardt AM, Wang SW. Advancements in protein nanoparticle vaccine platforms to combat infectious disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1681. [PMID: 33164326 DOI: 10.1002/wnan.1681] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
16 Das A, Ali N. Nanovaccine: an emerging strategy. Expert Rev Vaccines 2021;20:1273-90. [PMID: 34550859 DOI: 10.1080/14760584.2021.1984890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]